Prarabdha S. Phating1, Brijesh R. Mishra2*
1MD (Basic Principles & Ayurved compendia), Dept. of Basic Principles of Ayurveda and Ayurved Compendia, Shri Ayurveda Mahavidyalaya, Nagpur, Maharashtra, India.
2Principal, Professor, HOD & Guide, Dept. of Basic Principles of Ayurveda and Ayurved Compendia, Shri Ayurveda Mahavidyalaya, Nagpur, Maharashtra, India.
*Correspondence
Prarabdha S. Phating
Dept. of Basic Principles of Ayurveda and Ayurved Compendia
Associate Professor, Kashan University of Medical Sciences
Maharashtra, India
Email: phatingprarabdha25@gmail.com
Received: 04 Apr, 2026; Accepted : 16 Jul, 2026; Published : 27 Jul, 2026
Citation: Prarabdha S. Phating, Brijesh R. Mishra. “Role of Rakta Duṣṭi (Blood Vitiation) in Disease Pathophysiology: A Review” J Alter Med Ther (2026): 112. DOI: 10.59462/3068-532X.3.1.112.
Copyright: © 2024 Alzeer J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Rakta duṣṭi (blood vitiation) is a concept in Ayurveda describing pathological changes in the blood (rakta dhātu). Classical sources enlist numerous etiological factors (dietary, seasonal, emotional) that vitiate blood [1], and enumerate raktapradoṣaja vikaras (blood-borne disorders) such as kuṣṭha (skin disease), raktapitta (bleeding), and vātārakta (gouty arthritis) [2]. Modern parallels include systemic inflammation, immune dysregulation, oxidative stress and vascular dysfunction. This article reviews classical Ayurveda and biomedical literature on rakta duṣṭi, focusing on a chronic inflammatory arthritis (RA-like āmāvāta). We discuss classical definitions (with authoritative translations), diagnostic criteria, and proposed mechanisms correlating rakta duṣṭi to pathology. Blood purifying interventions– raktamokṣaṇa (bloodletting), rakta-śodhana formulations, and pañcakarma – are reviewed. This article presents future scope for the Researches in this direction. This scholarly synthesis integrates classical insight and contemporary research on blood pathology, aiming to stimulate interdisciplinary study.
Keywords: Rakta Duṣṭi, Blood Vitiation, Pathophysiology in Ayurveda, Srotoduṣṭi, Inflamatory disorders, Integrative medicine.
Introduction
The term Rakta duṣṭi literally means Blood Vitiation. Classical texts portray rakta as the second Dhātu (tissue) which is related to Pitta (bile) for nourishment and color. According to Charaka, many common factors – spoiled, sour or stale foods; excessive salt or alcohol; fermented curds; heat, anger or trauma – directly vitiate rakta [1]. Such vitiated blood becomes doṣhāhata (affected by doshas) and gives rise to raktapradoṣaja vikāras [2]. Sushruta similarly classifies rakta duṣṭi into Vātaja, Pittaja, Kaphaja or Saṃnipāta types, each with specific features [3]. In classical understanding, rakta duṣṭi manifests as skin eruptions, mucosal lesions, bleeding and systemic toxicity [2,4]. For example, Charaka states that if a disease is incurable by ordinary measures, it may be rakta-jāta and requires śodhana (purification) [2]. In short, rakta duṣṭi underlies conditions like kuṣṭha (leucoderma, psoriasis), raktapitta (hemorrhages), vātārakta (gout/arthritis), gulma (abscess) and others [2,5].
Modern pathophysiology corresponds to systemic inflammatory and hematologic disorders. Vitiated rakta can be seen as analogous to abnormal blood chemistry – e.g. elevated cytokines, immune complexes, oxidative products and dysfunctional cells – that initiate disease. Indeed, chronic inflammatory diseases involve precisely these blood-borne mechanisms. For instance, rheumatoid arthritis features autoantibodies and high TNF/IL-6 levels in blood [5]. Thus, we explore how rakta duṣṭi correlates with modern blood pathology, reviewing both classical texts and current biomedical studies.
Materials & Methods
A structured literature search has made to compile information on rakta duṣṭi. Classical references were obtained from critical editions of Charaka Saṃhitā, Suśruta Saṃhitā and Aṣṭāṅga Hṛdaya. Modern literature searches were run in PubMed, Google Scholar, and Ayurveda journals (JAIM, AYUSHDHARA) up to 2025. Search terms included “Rakta duṣṭi”, “Rakta vitiation”, “blood Ayurveda inflammation”, “raktamokṣaṇa clinical trial”, and disease-specific terms (e.g. “Amavata”). Both English translations of Sanskrit verses and peer-reviewed articles were collected. Inclusion criteria: sources providing definitions, etiologies, symptoms of rakta disorders; mechanistic hypotheses corresponding blood pathology to disease; and clinical studies of blood-purifying interventions (case reports, RCTs, animal studies). Non-English articles were excluded unless validated translations were available. We noted author, year, study design, sample, interventions and outcomes. Data synthesis involved mapping classical concepts to biomedical concepts (inflammation, oxidative stress, etc.). Quality assessment followed standard review methodology: classical sources were taken as primary data; modern trials were evaluated for controls and bias.
Discussion
Concept of Rakta Duṣṭi
Classical Definitions and Types: According to Charaka (Sutra Sthāna 24/5–10), rakta duṣṭi arises from various nidānas (causes) including vitiated food/drink, extremes of taste, vegetable poisons, overexertion, seasonal factors, and suppression of natural urges[1]. The quoted Charaka translation explains: “The blood is vitiated by habitual intake of spoiled or unsuitable food and liquids, overeating, acidic or pungent liquor, too much salty or alkaline substance, sour and pungent food… excessive curds, fermented liquors, decomposed food… Autumn season…”[1]. Sushruta lists analogous factors and emphasizes that unwholesome diet and emotions spoil rasa and rakta. He classifies raktaja vikāras by dosha dominance (Vātaja, Pittaja, Kaphaja, Dvidoṣha, Saṃnipāta)[3]. For example, Pittaja rakta-duṣṭi produces burning heat and bleeding, whereas Kaphaja yields heaviness and discoloration.
Symptoms/Signs (Lakṣaṇas): Charaka (Sutra 24/11–17) enumerates diseases arising from rakta duṣṭi: mukhapāka (mouth ulcers), akṣirāga (red eyes), gulma (abdominal tumor), upaḍāra (gum bleeding), visarpa (erysipelas-like spread), raktapitta (hemorrhage), vidrādhi (abscess), raktameha (blood in urine), pradara (vaginal discharge), and vātarakta (gout)[2]. He adds constitutional symptoms: “vaivarṇyam (skin discoloration), agnisāda (loss of appetite), pipāsa (thirst), gurugatrata (heaviness), santapā (fever), āruci (anorexia), śīrṣaśoola (headache)…”[2]. Note that tandra (lethargy), nidrā-atiyoga (excessive sleep), mental dullness, and skin rashes (kotha, pidaka, kuṣṭha, etc.) also appear [2]. Ayurvedic diagnosis of rakta duṣṭi therefore rests on these pitta/kapha symptoms plus persistent disease: Charaka explicitly states that ailments refractory to normal treatments should be considered of rakta duṣṭi origin[2]. In practice, clinicians examine pulse, urine, and local signs to identify rakta-vikāras.
Raktavāha Srotas and Srotodushti: The raktavāha srotas (blood channels) carry and nourish blood. Texts states srotodushti (channel blockage) occurs when doshas intoxicate rasa/ rakta, leading to tissue hypoxia and debris accumulation. In chronic venous ulcers, for example, Suśruta notes that vitiated doshas and raktaduṣṭi cause loss of vessel tone, stasis and ulceration [5]. This aligns with modern recognition that impaired microcirculation and inflammation worsen ulcer healing.
Analogues in Biomedicine: Contemporary medicine lacks a direct equivalent of rakta duṣṭi, but similar ideas appear in blood toxicology or systemic inflammation. Correlation of rakta duṣṭi to conditions of altered blood chemistry: elevated acute-phase reactants (CRP, ESR), inflammatory cytokines (TNF, IL-6, IL-17), oxidative metabolites, and immune complexes[5].
Correlation of rakta duṣṭi with molecular abnormalities
In modern terms, rakta duṣṭi implicates multiple pathophysiological pathways:
Representative Disease Mappings
We consider one disease each from inflammatory, dermatological, and metabolic categories:
Inflammatory Disease – Rheumatoid-like Arthritis (Āmāvāta/Vātārakṭa): Ayurvedic āmāvāta (rheumatism) involves āmala (undigested toxins) lodged in śleṣhmikā sṛṣtṣu (joints), with Vāta predominance. Some vātārakta presentations (gout) also implicate Rakta duṣṭi. Pathophysiologically, RA features synovial inflammation driven by autoantibodies and cytokines. In analogy, rakta duṣṭi could represent circulating immune complexes and cytokine-rich plasma fueling joint damage. Studies show that RA patients have higher ESR, CRP and serum IL-6 [6], and that their RBCs can adhere to inflammatory mediators [10]. Clinically, RA patients often benefit from leech therapy or bloodletting as adjuncts in Ayurvedic practice, reflecting the idea of removing “toxic blood.” Leech saliva contains hirudin and eglins (anti-coagulant, anti-inflammatory) which may alleviate synovitis and microvascular stasis. Although robust trials are sparse, small studies (e.g. Rajkumar et al., 2021) report symptomatic improvement after siravedha or jalaukāvacaraṇa in arthritic. Mechanistically, this that drawing even small volumes of blood lowers systemic cytokine load. In summary, rakta duṣṭi in āmāvāta maps to systemic autoimmunity and vascular inflammation (TNF-α, IL-6 elevation, endothelial activation) [11,15].
Raktamokṣaṇa (Bloodletting): Classical surgery of blood includes Jalaukāvacaraṇa (leech therapy) and Śiravedha (venesection). Sushruta states siravedha is the foremost remedy for rakta-jāta diseases[16]. Jalaukāvacaraṇa is specifically indicated in kuṣṭha and tvak-doṣa, as leech saliva releases hirudin, eglins etc. Evidence: A small open-label trial in chronic eczema found 4 leech sessions (weekly) significantly reduced Eczema Area and SCORAD scores (54–55% decline) and improved quality of life [17]. In psoriasis, multiple case reports highlight rapid improvement with just a few leech applications[14,18]. Biomedicine attributes such effects to anticoagulant and anti-inflammatory factors in leech saliva [19]. RCTs are limited, but one Iranian trial in diabetic neuropathy (40 patients) showed leech therapy provided greater symptom relief than gabapentin [15]. In summary, these data, though preliminary, support raktamokṣaṇa as reducing systemic inflammatory burden.
Blood Purifiers: Ayurveda prescribes formulations like Raktashodhaka herbs, Shankhpushpi etc, containing bitter-cooling herbs (Manjiṣṭhā, Daruharidrā, Nīm, Triphala, etc) for rakta śodhana. A case of chronic venous ulcer used Raktashodhaka Vati (Anantamūla, Daruharidrā, etc) with medicinal powders, achieving complete healing in a month [20]. These herbs have documented anti-inflammatory, antioxidant and microcirculatory effects (e.g. Manjiṣṭhā’s alizarin pigment scavenges ROS). No large trials exist, but small studies (e.g. Jain et al., 2022) report Kuṣṭhaghna herbals improving psoriasis scores. Future research should involve controlled trials of blood-purifying formulations with endpoints like serum TNF-α, IL-6, CRP, or biopsy markers (e.g. reduction in neutrophils in skin).
Pañcakarma (Purification Therapies): Panchakarma regimens aim to dosha-balance systemically. For rakta duṣṭi, Virechana (purgation) is often used to eliminate Pitta-Rakta toxins via the gut [4] . Nasyam (nasal drops) and external therapies (medicated oils) may be employed to pacify shiro-roga due to blood impurities. Clinical evidence is sparse, but trans-disciplinary integration studies (Ayurveda + rheumatology) often include Panchakarma. Well-controlled research should measure biochemical outcomes (cytokines, oxidative stress) alongside clinical scales in conditions like psoriasis or arthritis after Panchakarma.
|
Ayurvedic Entity |
Dosha / Dhātu |
Example Condition |
Biomedical Correlate |
|
Kuṣṭha (Skin disease) |
Tridoṣa (↑Pitta, Rakta) |
Eczema, Psoriasis |
Immune-mediated dermatitis (IL-17/TNF↑) [7], oxidative stress |
|
Vātārakṭa (Gouty arthritis) |
Vāta+Pitta (Rakta dhātu) |
Gout, RA-like arthritis |
Crystal/inflammatory arthritis (IL-1, TNF) |
|
Āmāvāta (Autoimmune rheum.) |
Vāta+Kapha with Āma |
Rheumatoid arthritis analogue |
Autoimmune synovitis (auto-Ab, IL-6, TNF) [6] |
|
Raktapitta (Hemorrhage) |
Pitta (Rakta dhātu) |
Epistaxis, GIT bleeding |
Coagulopathy/vascular fragility |
|
Sannipātaja Rakta Duṣṭi |
Vāta+Pitta+Kapha (Tri-doṣa) |
Multi-system illness |
Sepsis-like syndrome (cytokine storm) |
Table 1. Comparison of Ayurvedic categories involving blood (Rakta) with modern biomedical syndromes and pathophysiology.
|
Study (Ref) |
Design |
Population/Condition |
Intervention |
Outcome |
Comments |
|
Thappa et al. (2015) [17] |
Open-label (n=27) |
Chronic eczema (vicharchikā) |
Leech therapy (4 weekly sittings) |
EASI↓54.4%, SCORAD↓55%, DLQI↑62% (p<0.01) |
Uncontrolled trial – suggests leech efficacy |
|
Bhatted et al. (2023) [14] |
Case report (1) |
Palmoplantar psoriasis (vipādika) |
Ayurvedic medicines + 3 leech applications |
Marked improvement in itch, scaling, erythema in ~3 weeks |
Single case – rapid effect |
|
Sisodia et al. (2025) [20] |
Case report (1) |
Chronic venous ulcer |
Raktashodhaka Vati (oral) + herbal dusting |
Complete ulcer healing (4 weeks) |
Single case – suggests herb efficacy |
|
Chugh et al. (2018) – reference only |
Review |
Various raktaja conditions |
Various (jalauka, virechana, herbs) |
Reported symptomatic relief (anecdotal) |
Narrative Ayurveda review |
Table 2. Summary of key studies on interventions targeting rakta duṣṭi. (EASI=Eczema Area Severity Index; SCORAD=SCORing Atopic Dermatitis; DLQI=Dermatology Life QOL Index; NDS/NSS=Neuropathy scores.) Quality varies from case reports (low) to small trials (low–moderate).
Research Gaps and Future Directions
Despite plentiful theoretical claims, high-quality evidence is scarce. Few RCTs have tested raktamokṣaṇa or rakta-śodhaka herbs against control. Future research should include: Clinical Trials jalaukāvacaraṇa or siravedha in psoriasis, arthritis or diabetic complications, with proper controls. Outcome measures must include both clinical scales and laboratory markers. Also, biomarker Studies: Pre/post intervention studies measuring cytokines (TNF-α, IL-1β, IL-6, IL-17), acute-phase proteins, antioxidant status (glutathione, SOD activity), endothelial markers (NO, adhesion molecules) and rheological parameters (blood viscosity, RBC deformability). This would quantify blood purification. Standardization: Developing standardized rakta-śodhaka formulations (with known phytochemical profiles) and protocols for leech therapy (dose, frequency) to allow reproducibility. Integrative Trials: Combining Ayurvedic treatments with conventional therapy (e.g. methotrexate + siravedha in RA) and comparing outcomes, to bridge traditional and biomedical approaches.
In summary, rakta duṣṭi likely underlies a spectrum of inflammatory disorders by mediating blood-borne toxicity. Classical descriptions align with modern concepts of systemic inflammation and hematological dysfunction. There is promising preliminary evidence (especially with bloodletting) but rigorous studies are needed. Clarifying the biomedical correlates of rakta duṣṭi (cytokine profiles, oxidative stress) will enable testing Ayurvedic interventions in scientific trials.
Conclusion
Ayurvedic texts richly describe rakta duṣṭi as a root of many diseases, from skin conditions to metabolic syndrome[1,2]. Modern research confirms that abnormal blood constituents (inflammation, autoimmunity, oxidative damage) are central to conditions like arthritis, psoriasis and diabetes [6- 8]. Interventions such as raktamokṣaṇa and blood-purifying herbs aim to remove these pathogenic factors. Although classical wisdom and some clinical reports support their use, well-designed trials with biochemical endpoints are needed. Bridging Ayurvedic theory with biomedical evidence offers a rich avenue for future research – for example, measuring how leech therapy or herbal rakta śodhana changes cytokine levels or endothelial function. Our review provides a comprehensive survey of the concept of rakta duṣṭi, illustrating its relevance to modern pathophysiology and highlighting opportunities for integrative studies.
References